BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND KMT2C, ENSG00000055609, MLL3, 58508
31 results:

  • 1. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.
    Shin W; Yun J; Han K; Park DG
    Genes Genomics; 2023 Aug; 45(8):989-1001. PubMed ID: 37277571
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. mll3 regulates the
    Zhu C; Soto-Feliciano YM; Morris JP; Huang CH; Koche RP; Ho YJ; Banito A; Chen CW; Shroff A; Tian S; Livshits G; Chen CC; Fennell M; Armstrong SA; Allis CD; Tschaharganeh DF; Lowe SW
    Elife; 2023 Jun; 12():. PubMed ID: 37261974
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
    Ko KP; Huang Y; Zhang S; Zou G; Kim B; Zhang J; Jun S; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Park JI
    Gastroenterology; 2023 Sep; 165(3):613-628.e20. PubMed ID: 37257519
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. PGNneo: A Proteogenomics-Based Neoantigen Prediction Pipeline in Noncoding Regions.
    Tan X; Xu L; Jian X; Ouyang J; Hu B; Yang X; Wang T; Xie L
    Cells; 2023 Mar; 12(5):. PubMed ID: 36899918
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated genomic analyses of hepatocellular carcinoma.
    Chang YS; Tu SJ; Chen HD; Hsu MH; Chen YC; Chao DS; Chung CC; Chou YP; Chang CM; Lee YT; Yen JC; Jeng LB; Chang JG
    Hepatol Int; 2023 Feb; 17(1):97-111. PubMed ID: 36472800
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?
    Kantarcıoğlu M; Yıldırım G; Akpınar Oktar P; Yanbakan S; Özer ZB; Yurtsever Sarıca D; Taşdelen S; Bayrak E; Akın Balı DF; Öztürk S; Akçalı KC; Ezer Ü; Kürekçi AE
    Turk J Gastroenterol; 2023 Feb; 34(2):161-169. PubMed ID: 36262101
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas.
    Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Yamamoto Y; Ashida R; Ohgi K; Nagashima T; Yamaguchi K
    J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):269-282. PubMed ID: 35918906
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The potential, analysis and prospect of ctDNA sequencing in hepatocellular carcinoma.
    Ding Y; Yao J; Wen M; Liu X; Huang J; Zhang M; Zhang Y; Lv Y; Xie Z; Zuo J
    PeerJ; 2022; 10():e13473. PubMed ID: 35602894
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive Analysis of Large-Scale Transcriptomes from Multiple cancer Types.
    Nong B; Guo M; Wang W; Songyang Z; Xiong Y
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946814
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
    Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
    Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics.
    Jiao J; Sanchez JI; Thompson EJ; Mao X; McCormick JB; Fisher-Hoch SP; Futreal PA; Zhang J; Beretta L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299031
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma.
    Hou P; Su X; Cao W; Xu L; Zhang R; Huang Z; Wang J; Li L; Wu L; Liao W
    Diagn Pathol; 2021 Apr; 16(1):29. PubMed ID: 33832503
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma.
    Yi B; Wu T; Zhu N; Huang Y; Yang X; Yuan L; Wu Y; Liang X; Jiang X
    J Nanobiotechnology; 2021 Mar; 19(1):74. PubMed ID: 33726759
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions.
    Chalmers ZR; Burns MC; Ebot EM; Frampton GM; Ross JS; Hussain MHA; Abdulkadir SA
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):558-566. PubMed ID: 33420417
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.
    Ishida S; Akita M; Fujikura K; Komatsu M; Sawada R; Matsumoto H; Saegusa J; Itoh T; Kakeji Y; Zen Y
    Hum Pathol; 2021 Apr; 110():1-10. PubMed ID: 33359239
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma.
    Zheng Y; Tang L; Chen G; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820983284. PubMed ID: 33355042
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases.
    Akita M; Hong SM; Sung YN; Kim MJ; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Histopathology; 2020 Jun; 76(7):1005-1012. PubMed ID: 32181510
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.